Cascade-Amplified Microfluidic Detection of Tumor Biomarkers via Metal-DNA Nanospheres Activating CRISPR-Cas12a Assay
Analytical Chemistry · 2026
DOI: 10.1021/acs.analchem.6c03578 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2026. Verfasst von Wenjian Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastric and Hernia Surgery, Nanjing Drum Tower Hospital, College of Engineering and Applied Sciences, State Key Laboratory of Analytica…. Hauptthemen laut MEDLINE: Biomarkers, Tumor, CRISPR-Cas Systems, Nanospheres, DNA. Die Arbeit nennt 67 Literaturangaben. Gefördert von: State Key Laboratory of Analytical Chemistry for Life Sciences, Fundamental Research Funds for the Central Universities, Jiangsu Provincial Key Research and Development Program.
Abstract (Originalsprache)
The development of ultrasensitive protein detection platforms is pivotal for early cancer diagnosis, yet existing methods are often constrained by inefficient “protein-to-signal” conversion and complex instrumentation. While CRISPR-Cas-based biosensors offer higher sensitivity for nucleic acids, their application in protein analysis is fundamentally limited by the low nucleic acid loading capacity and tedious functionalization of traditional inorganic signal carriers such as gold nanoparticles and metal–organic frameworks (MOFs). Herein, we report a highly efficient signal-transduction strategy utilizing Fe-coordinated DNA nanospheres (FDNSs)─a programmable, metal-nucleic acid assembly─as a high-capacity DNA reservoir for amplified biomarker sensing. Unlike conventional surface-modified inorganic nanoparticles, the solid-core FDNSs achieve an unprecedented DNA loading density and exhibit specific stimulus-responsive degradation. In this FACC (FDNS-activated CRISPR chip) platform, the recognition of tumor biomarkers triggers the rapid collapse of FDNSs, releasing a massive flux of barcode DNA that subsequently activates the CRISPR-Cas12a system within a microfluidic device. This dual-amplification architecture enables the ultrasensitive quantification of prostate-specific antigen (PSA) and carcinoembryonic antigen (CEA) with detection limits of 0.028 fg/mL and 0.0265 fg/mL, respectively. By replacing complex inorganic carriers with this programmable DNA assembly, our platform simplifies the sensing workflow and significantly enhances sensitivity, providing a robust and portable solution for cancer screening in resource-limited settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastric and Hernia Surgery, Nanjing Drum Tower Hospital, College of Engineering and Applied Sciences, State Key Laboratory of Analytical Chemistry for Life Science, Nanjing University, Nanjing210023, China.
- Key Laboratory of Flexible Electronics & Institute of Advanced Materials, Nanjing Tech University, Nanjing211816, China.
- Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing210006, China.
- School of Medical Imaging, Wannan Medical University, Wuhu241002, China.
- Academy of National Food and Strategic Reserves, Reserves Administration, Beijing100037, China.
- Department of General Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing, University Medical School, Nanjing210008, China.
ORCID-Profile: Yanfeng Gao, Hongmei Liu, Yujun Song
Förderung
- State Key Laboratory of Analytical Chemistry for Life Sciences
- Fundamental Research Funds for the Central Universities
- Jiangsu Provincial Key Research and Development Program
- National Basic Research Program of China (973 Program)
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Zhao, W., Luan, X., Long, W., Li, Z., Dong, P., He, B., Gao, Y., Liu, H., Yin, Y., & Song, Y. (2026). Cascade-Amplified Microfluidic Detection of Tumor Biomarkers via Metal-DNA Nanospheres Activating CRISPR-Cas12a Assay. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c03578
Vancouver
Zhao W, Luan X, Long W, Li Z, Dong P, He B, et al. Cascade-Amplified Microfluidic Detection of Tumor Biomarkers via Metal-DNA Nanospheres Activating CRISPR-Cas12a Assay. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.6c03578
BibTeX
@article{Zhao2026,
author = {Zhao, Wenjian and Luan, Xiaowei and Long, Wenxiu and Li, Zhi and Dong, Ping and He, Bangshun and Gao, Yanfeng and Liu, Hongmei and Yin, Yi and Song, Yujun},
title = {Cascade-Amplified Microfluidic Detection of Tumor Biomarkers via Metal-DNA Nanospheres Activating CRISPR-Cas12a Assay},
journal = {Analytical Chemistry},
year = {2026},
doi = {10.1021/acs.analchem.6c03578}
}
EUVIMED